Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
PERSpective

Indian Pediatr 2021;58: 315-319

E-cigarettes and Vaping: A Global Risk for Adolescents

 

Swati Y Bhave1 and Nicholas Chadi2

From 1AACCI – Association of Adolescent and Child Care in India , Mumbai, India; and 2Division of Adolescent Medicine, Department of Pediatrics, Sainte-Justine University Hospital Centre, Université de Montréal, Montreal, QC, Canada.

Correspondence to: Dr Swati Y Bhave, 601 Alliance Shanti, Shantisheela Co-operative society, Pune 411 004, Maharashtra, India.
Email: [email protected]

    


While the marketing and sale of electronic cigarettes (e-cigarettes) in India is forbidden since September, 2019, vaping represents a significant risk to the health and safety of Indian adolescents. Though the prevalence of youth e-cigarette use in India remains unknown, pediatricians are often brought to provide care to youth who vape. In this commentary, background information on e-cigarettes including a review of the different types of vaping devices and of the substances contained in e-cigarette liquids is provided. The short- and long-term health risks associated with vaping, including risks for the developing brain, acute lung injuries and long-term mental health effects, and a practical approach for clinical management of e-cigarette use for Indian pediatricians is presented. Public health measures to prevent and reduce youth vaping and a review of current Indian laws and policies around e-cigarette use are also mentioned.

Keywords: ENDS, Nicotine, Smoking, Substance use.


In the span of less than a decade, electronic cigarettes, also called electronic nicotine delivery systems (ENDS), or e-cigarettes, have completely changed the landscape of nicotine product use among adolescents and young adults [1]. Initially introduced as a harm reduction and smoking cessation strategy for adult cigarette smokers, e-cigarettes and other vaping devices have rapidly become popular among youth around the world. Aggressive youth-directed marketing from e-cigarette companies, easy and widespread access to vaping products, low cost, low perceptions of risk, youth-friendly flavors and designs, as well as highly effective nicotine delivery leading to intense psychoactive effects are a few reasons for their popularity [2].

While there is a wide variety of e-cigarettes and vaping products, most of them share a common mechanism. A reservoir or cartridge filled with an e-cigarette liquid (or e-liquid) connected to a battery-powered heating metal coil, produces a mix of vapor and fine particles (aerosol), which is then inhaled through a mouthpiece [3]. Most e-liquids contain nicotine, often in high concentrations and flavoring agents. The solvents used for nicotine or flavored products are water based like propylene glycol. E-liquids may also be oil-based and contain substances like tetrahydrocannabinol (THC), the main psychoactive component found in cannabis [4]. They also contain small amounts of chemicals and heavy metals such as acrolein, acetaldehyde, nickel and lead, which can be toxic or carcinogenic Table I [2,5].

Table I Substances Found in E-cigarette Liquids and Aerosols
Substances identified Carcinogens
Nicotine Class 1 Potent carcinogens
Humectants/solvents (e.g. propylene glycol and glycerol) Formaldehyde
Flavorings Benzene4-(methylnitroso-amino)-1-(3-pyridyl)-1-
Carbonyl compounds (including aldehydes) Butanone
Tobacco alkaloids Cadmium
Tobacco-specific nitrosamines (TSNAs) Class 2a Probable carcinogens
Free radicals and reactive oxygen species (ROS) Acetaldehyde
Volatile organic compounds (VOCs) and phenolic compounds 1,2-Propanediol
Residual solvents Isoprene
Polycyclic aromatic hydrocarbons (PAHs) Benzo(a)pyrene
Phthalates Benzo(b)fluoranthene
Metals  Benzo(k)fluoranthene
Caffeine Indenol(1,2,3-cd) pyrene
Pharmaceutical compounds Chromium
+Microorganisms  Lead
Substances present in combustible cigarettes but typically Class 2b Possible carcinogens
not identified in e-cigarette aerosols Acrolein
Carbon monoxide Toluene M,p-xylene
Tar Phenol
Benzo(e)pyrene
Benzo(g,h,i) perylene
Chrysene
Nickel (more in e cig.)
Adapted from reference 11.

The use of e-cigarettes among youth is increasing in most parts of the world [6]. In the US, the prevalence of past-month e-cigarette use increased from 0.6% in 2011 to 10.5% in 2019 among middle school students (ages 11-14) and from 1.5% to 27.5% among high school students (ages 14-18) [7]. In Great Britain, lifetime e-cigarette use increased from 7% in 2016 to 11% in 2017 among 11-16 year-olds [8]. Estimates of lifetime e-cigarette use across Asia include 4.4% among 15-17 year-old adolescents in Taiwan [9], and 9.3% among secondary school students in Hong Kong [10].

E-CIGARETTE AND VAPING PRODUCTS

E-cigarettes come in many different shapes and sizes. Earlier models often resembled traditional cigarettes and had a limited appeal for youth [11]. The first surge in popularity among teens occurred between 2013-2015 with the proliferation of pen-like and larger, complex devices made available in a wide range of youth-friendly flavours [12]. A second rapid increase in popularity was between 2017-2019 with the arrival of small, pod-based devices using pre-filled cartridges [13]. Fig. 1 presents a schematic representation of various e-cigarette devices [14].

Reproduced with permission from the Centers for Disease Control and Prevention, USA [14].

Fig. 1 E-cigarettes and other vaping devices.

The amount of nicotine contained in most e-liquids varies between 15 and 50 mg/mL. E-cigarettes exposes adolescents to nicotine toxicity and potential nicotine overdose [15] as they can absorb high amounts of nicotine in a short time period [16,17]. For example, a typical 2mL e-cigarette pod at 5% concentration would contain 100 mg of nicotine which could be consumed in as little as one hour with uninterrupted use [17,18]. The lethal dose of nicotine has been said to be between 30 and 60 mg for adults, but may be much higher [19].

HEALTH RISKS

E-cigarettes are associated with several acute and long-term health risks. Supp. Table I summarizes the properties and physiological effects of the different constituents found in e-cigarette liquids [11].

Use of nicotine during adolescence is associated with altered brain development and long-term impairments in memory, attention capacity and executive functioning [20-23]. Consuming large amounts of nicotine through aping can lead to nicotine toxicity, which presents with headaches, abdominal pain, nausea, vomiting, heart palpitations, hand tremors, difficulty concentrating, and in some cases, seizures and cardiac arrhythmia. Nicotine is also a long-term risk factor for poor cardiovascular health [ 24-26].

Regular nicotine use through vaping can also lead to withdrawal symptoms if adolescents try to quit or are temporarily unable to access vaping products. Withdrawal symptoms can appear after as little as a few weeks of use and can interfere with normal daily functioning [27-29].

Acute injuries like facial and limb burns due to malfunction of vaping devices have also been described [30]. Additionally, vaping aerosols include carcinogenic and irritating substances that may lead to chronic respiratory symptoms such as cough, bronchitis, asthma exacerbation and decreased exercise tolerance [31,32].

More than 2,800 cases of severe e-cigarette or vaping-associated lung injury (EVALI) were reported in Canada and the US in 2019 and early 2020, of which approximately 15% cases were reported in youth under the age of 18 years [33]. EVALI consists of a sterile inflammatory pneumonitis that presents with cough, chest pain, and shortness of breath, which can be severe and lead to hospitalization and even death [33]. While no cases have been reported in India, and much remains unknown about this condition, it is suspected that vitamin E acetate (found in several cannabis-containing e-liquids) may lead to such presentations [33].

Clinical Management of E-Cigarette Use

Screening and Brief Intervention

Pediatricians should ask adolescent patients if they have tried vaping, if they currently vape, and discuss vaping-associated health risks with all adolescents. The discussion should include commercial brand names for more clarity and details should be asked about products and substances used, motives, context, frequency, intensity and motivations to quit if applicable [34,35]. Using standardized scales for nicotine dependence (such as the Hooked on Nicotine Checklist) or diagnostic criteria for cannabis use disorder according to the Diagnostic and Statistical Manual of Mental Disorders (DSM–5) can also be useful to understand the severity of the vaping habit and addiction to nicotine and/or cannabis.

A 5-step Algorithm–The 5 A’s

Ask, Advise, Assess, Assist, and Arrange–initially developed for smoking cessation, can also be a helpful framework for an effective vaping counseling intervention [35,36]. After asking about vaping, pediatricians should advise all adolescents not to initiate or to quit vaping and discuss one or two of the health risks associated with vaping (e.g. EVALI). Pediatricians can then assess the young person’s motivation to quit or cut down, for instance, by using a 10-point scale (i.e. "on a scale from 1 to 10, how motivated are you to quit/cut down on vaping?"). Based on the response, the pediatrician can then offer to assist the adolescent with vaping cessation. Finally, pediatricians should arrange a follow-up plan, involving families and/or other health care providers when applicable.

Vaping Cessation

As there are no evidence-based pharmaceutical treatments tested specifically for adolescents with vaping addiction, the first line of treatment for vaping cessation relies on behavioral strategies. Strategies that have proven effective for tobacco dependence should be considered including individual or group counseling, motivational inter-viewing, cognitive-behavioral therapy, contingency management, mindfulness-based interventions, as well as smartphone and web-based strategies [34,35].

Considering that most vaping liquids contain nicotine, often in high amounts, nicotine replacement therapy such as patches, gums and lozenge can be used safely with adolescents in addition to behavioral strategies [34]. The use of anti-craving medications such as bupropion and varenicline can also be considered alone or in addition to nicotine replacement [34].

E-cigarettes for Smoking Cessation: Adults vs Adolescents

A recent Cochrane review suggests that among adults, e-cigarettes used alone or in combination with other pharmaceuticals or behavioral methods may be of similar effectiveness for smoking cessation as approved nicotine replacement products [36]. People who oppose the recent ban on e-cigarettes in India, support that e-cigarettes are a valuable tool for Tobacco Harm Reduction (THR) as an aid for adult smokers hoping to quit smoking. A meta-analysis of 299 articles established that newer generations of e-cigarettes may serve as an efficient means of meeting the nicotine demand of a person addicted to smoking, with significantly reduced health consequences compared to conventional cigarettes [37].

However, whether this adult data can be extrapolated to youth remains unknown [36]. The evidence for pharmacotherapy for youth e-cigarette cessation remains extremely limited. Adolescents, with a still-developing pre-frontal cortex, are more vulnerable to the addictive properties of nicotine, which may impact the level to which adult data can be extrapolated.

Although, e-cigarette use may cause youth to transit to combustible tobacco products, it could also increase adult cessation of combustible tobacco cigarettes. The net public health effect, harm or benefit, of e-cigarettes depends on three factors: i) Effect on youth initiation of combustible tobacco products, ii) Effect on adult cessation of combustible tobacco products, and iii) Intrinsic toxicity. E-cigarette use by adult smokers needs to lead to long-term abstinence from combustible tobacco cigarettes to lead to considerable benefit to public health. Without that, e-cigarette use could cause considerable harm due to the inherent harms of exposure to e-cigarette toxicants and to the harms related to potential subsequent combustible tobacco use by those who begin using e-cigarettes in their youth [11].

Prevention and Public Health Measures

In January 2020, the Society for Adolescent and Medicine issued a new policy statement by a collaborative group of Adolescent Medicine Providers from India, Canada, the US and the UK with recommendations to prevent e-cigarette use and protect youth from the harms of e-cigarettes (Box I) [38].

Box I Suggestions from the Society of Adolescent Health and Medicine to Prevent e-Cigarette Use

• Advocate for policies and regulations to prevent marketing and sales of e-cigarettes products to youth.

• Support public health–led education campaigns and educational curricula for schools, community programs, and health providers warning about the health risks of e-cigarette use by adolescents and young adults (AYAs).

• Increase research to develop evidence-based guidelines for e-cigarette prevention and cessation for AYAs.

• Support training for health providers to integrate screening for e-cigarette use into routine health visits for AYAs and increase the availability of evidence-based counseling and treatment resources for e-cigarette use cessation.

Reproduced with permission from Reference [38].

E-CIGARETTE USE IN INDIA

India has well-established tobacco cessation strategies, under the umbrella of the National Tobacco Control Programme (NTCP). The support for tobacco cessation is multipronged, ranging from brief advice to comprehensive counselling and support for nicotine-replacement therapy [39]. Tobacco consumption, mainly cigarette smoking, has declined by 1% between 2010 and 2017 in India, in response to several tobacco control measures [40]. There are recent surveys regarding tobacco consumption and e-cigarette sales and consumption in India [41]. A study on Indian Internet e-cigarette search query patterns concluded that searches for vaping products by Indians have been increasing over time [42].

Some of the most serious concerns have been expressed by school principals in Delhi regarding the increasing trend of youth vaping among young students [43]. The sale of vaping devices has spiraled upward since their introduction in the Indian market in 2007 to the point that many schools have become surrounded by vape shops [43]. In September 2019, India became one of the first countries to enact a complete ban on all e-cigarette products. This ban followed an intense period of discussion and debate weighing the advantages and potential disadvantages of such a ban [44], and the publication of a white paper from the Indian Council of Medical Research a few months prior [45].

CONCLUSION

Though the ban on e-cigarettes in India was mainly implemented to prevent e-cigarette use among youth, one must consider its potential negative effects among adults. There is still very limited data in India regarding use of e-cigarettes among adolescents, and even less so, regarding its effects on rates of youth use. Pediatricians can play a vital role in protecting youth against the known and potential risks of e-cigarette use. By staying informed on recent developments related to the health effects of e-cigarettes and offering effective screening and treatment interventions to youth who use them, Indian pediatricians can help mitigate the impacts of what has become a global risk for adolescents.

Acknowledgment: Dr. Samir Shah for help with referencing and table creation

Funding: None; Competing interests: None stated.

REFERENCES

1. Chadi N, Hadland SE, Harris SK. Understanding the implications of the "vaping epidemic" among adolescents and young adults: A call for action. Subst Abuse. 2019;40:7-10.

2. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. 2016;1:5.

3. American Academy of Pediatrics: Section on Tobacco Control. Electronic Nicotine Delivery Systems. Pediatrics. 2015;136:1018-26.

4. Breitbarth AK, Morgan J, Jones AL. E-cigarettes – An unintended illicit drug delivery system. Drug Alcohol Depend. 2018;192:98-111.

5. Huang SJ, Xu YM, Lau ATY. Electronic cigarette: A recent update of its toxic effects on humans. J Cell Physiol. 2018; 233:4466-78.

6. Yoong SL, Stockings E, Chai LK, et al. Prevalence of electronic nicotine delivery systems (ENDS) use among youth globally: A systematic review and meta-analysis of country level data. Aust N Z J Public Health. 2018;42:303-8.

7. Cullen KA, Gentzke AS, Sawdey MD, et al. E-Cigarette use among youth in the United States. JAMA. 2019;322: 2095-103.

8. Bauld L, MacKintosh AM, Eastwood B, et al. Young people’s use of e-cigarettes across the United Kingdom: Findings from five surveys 2015-2017. Int J Environ Res Public Health. 2017;14:973.

9. Chang HC, Tsai YW, Shiu MN, Wang YT, Chang PY. Elucidating challenges that electronic cigarettes pose to tobacco control in Asia: A population-based national survey in Taiwan. BMJ. 2017;7:e014263.

10. Chen J, Ho SY, Leung LT, Wang MP, Lam TH. School-level electronic cigarette use prevalence and student-level tobacco use intention and behaviours. Sci Rep. 2019;9:1690.

11. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board or Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic nicotinic-delivery systems. Public Health Consequences of E-Cigarettes. The National Academies Press; 2018:29894118.

12. Boak A, Elton-Marshall T, Mann RE, Hamilton HA. Drug use among Ontario students, 1977-2019: Detailed findings from the Ontario Student Drug Use and Health Survey (OSDUHS). Centre for Addiction and Mental Health. 2020

13. Singh S, Windle SB, Filion KB, et al. E-cigarettes and youth: Patterns of use, potential harms, and recommendations. Prev Med (Baltim). 2020;133:106009.

14. NIDA. Vaping Devices (2020, January 8). Vaping Devices (Electronic Cigarettes) Drug Facts. Accessed on June 24, 2020. Accessed from: https://www.drugabuse.gov/ publications/drugfacts/vaping-devices-electronic-cigarettes

15. Chadi N, Moore-Hepburn C, Beno S, et al. Vaping-related injury and illness among Canadian children and adolescents: A one-time survey of pediatric providers. BMJ. Paediatrics Open. 2020;4:e000840.

16. Blank MD, Pearson J, Cobb CO, et al. What factors reliably predict electronic cigarette nicotine delivery? Tobacco Control. 2020;29:644-51.

17. Baassiri M, Talih S, Salman R, et al. Clouds and "throat hit": Effects of liquid composition on nicotine emissions and physical characteristics of electronic cigarette aerosols. Aerosol Sci Technol. 2017;51:1231-39.

18. EL-Hellani A, Salman R, El-Hage R, et al. Nicotine and carbonyl emissions from popular electronic cigarette products: Correlation to liquid composition and design characteristics. Nicotine Tob Res. 2018;20:215-23.

19. Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol. 2014;88:5-7.

20. Harvey J, Chadi N, Di Meglio G, et al. Strategies to promote smoking cessation among adolescents. Paediatr Child Heal. 2016;21:201-4.

21. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: A systematic review and meta-analysis. JAMA Pediatr. 2017;171:788-97.

22. Goriounova NA, Mansvelder HD. Nicotine exposure during adolescence alters the rules for prefrontal cortical synaptic plasticity during adulthood. Front Synaptic Neurosci. 2012; 4:3.

23. Jankowski M, Krzystanek M, Zejda JE, et al. E-cigarettes are more addictive than traditional cigarettes—A study in highly educated young people. Int J Environ Res Public Health. 2019;16:2279.

24. Shao XM, Fang ZT. Severe acute toxicity of inhaled nicotine and e-Cigarettes: Seizures and cardiac arrhythmia. Chest. 2020;157:506-8.

25. Spindle TR, Talihab S, Hiler MM, et al. Effects of electronic cigarette liquid solvents propylene glycol and vegetable glycerin on user nicotine delivery, heart rate, subjective effects, and puff topography. Drug Alcohol Depend. 2018;188:193-9.

26. Buchanan ND, Grimmer JA, Tanwar V, Schwieterman N, Mohler PJ, Wold LE. Cardiovascular risk of electronic cigarettes: A review of preclinical and clinical studies. Cardiovas Res. 2020;116:40-50.

27. Mclaughlin I, Dani JA, De Biasi M. Nicotine withdrawal. Curr Top Behav Neurosci. 2015;24:99-123.

28. Yingst JM, Foulds J, Veldheer S, et al. Nicotine absorption during electronic cigarette use among regular users. PLoS One. 2019;14:e0220300.

29. Yingst JM, Hrabovsky S, Hobkirk A, Trushin N, Richie JP, Foulds J. Nicotine absorption profile among regular users of a pod-based electronic nicotine delivery system. JAMA Netw Open. 2019;2:e1915494.

30. Hassan S, Anwar MU, Muthayya P, Jivan S. Burn injuries from exploding electronic cigarette batteries: An emerging public health hazard. J Plast Reconstr Aesthet Surg. 2016;69:1716-8.

31. McConnell R, Barrington-Trimis JL, Wang K, et al. Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195:1043-9.

32. Clapp PW, Jaspers I. Electronic cigarettes: Their constituents and potential links to asthma. Curr Allergy Asthma Rep. 2017;17:79.

33. Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: Characteristics of a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury - United States, August 2019-January 2020. Morb Mortal Wkly Rep. 2020;69:90-4.

34. Hadland SE, Chadi N. Through the haze: What clinicians can do to address youth vaping. J Adolesc Heal. 2020;66:10-4.

35. Harvey J, Chadi N, and Canadian Paediatric Society, Adolescent Health Committee. Preventing smoking in children and adolescents: Recommendations for practice and policy. Paediatr Child Health. 2016;21:209-14.

36. Hartmann-Boyce J, Mc Robbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2020;10:CD010216.

37. Das S, Choudhary Y, Thangaminal V, Sharan RN. A systematic review and meta-analysis on the health and safety implications of electronic nicotine delivery systems. Indian J Clin Pract. 2019;29:1016-26..

38. The Society for Adolescent Health and Medicine. Protecting youth from the risks of electronic cigarettes. J Adoles Health. 2020;66:127-31.

39. Mohan P, Lando HA, Panneer S. Assessment of tobacco consumption and control in India. Indian J Clin Med. 2018;9:117991611875928.

40. World Health Organization. GATS 2: Global Adult tobacco survey, India 2016-17. Accessed on December 26, 2020. Available from: https:// www.who.int/tobacco/surveillance/survey/gats/GATS_India_2016-17_FactSheet.pdf

41. Sharan RN, Chanu TM, Chakrabarty TK, Farsalinos K. Patterns of tobacco and e-cigarette use status in India: A cross-sectional survey of 3000 vapers in eight Indian cities. Harm Reduct J. 2020;17:21.

42. Thavarajah R, Mohandoss AA, Ranganathan K, Kondalsamy-Chennakesavan S. Influence of legislations and news on Indian internet search query patterns of e-cigarettes. J Oral Maxillofac Pathol. 2017;21:194-202.

43. Chettri S. Vaping new headache for Delhi schools as fad catches on. Times of India. May 26, 2019. Available from: https://timesofindia.indiatimes.com/city/delhi/delhi-vaping-new-headache-for-schools-as-fad-catches-on/articleshow/69501206.cms

44. Kaur J, Rinkoo AV. A call for an urgent ban on e-cigarettes in India – A race against time. Global Hlth Promot. 2015; 22:71-4.

45. Chakma JK, Dhaliwal RS, Mehrotra R. White paper on electronic nicotine delivery system. Indian J Med Res. 2019;149:574-83.

 

Copyright © 1999-2021 Indian Pediatrics/font>